secwatch.observer — SEC 8-K summary
======================================

Issuer:     CV Sciences, Inc. (CVSI)
CIK:        0001510964
Form:       8-K
Filed at:   2022-09-27T23:59:59+00:00
Accession:  0001510964-22-000076
Event type: litigation
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CV Sciences reaches preliminary settlement of six derivative lawsuits; court grants approval
--------------------------------------------------------------------------------

- Court granted preliminary approval on Sept 21, 2022; final hearing set for Nov 14, 2022.
- Settlement includes $275,000 in attorneys' fees to plaintiffs and corporate governance reforms.
- Defendants deny all wrongdoing; settlement is not an admission of liability.
- Six derivative actions consolidated: Depoti, Radcliffe, Tarangelo, Francis, Berry, Menna.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1510964/000151096422000076/0001510964-22-000076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1510964/000151096422000076/cvsi-20220921.htm
  HTML page:      https://secwatch.observer/filing/0001510964-22-000076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer